News and Events

NovaBiotics Named as One of Scotland’s Top Ten Biotech Companies to Watch Out For

Jul 7, 2021

NovaBiotics Announces Cysteamine Bitartrate (NM002) Included in REMAP-CAP Phase 3 Clinical Trial for Community Acquired Pneumonia

Jun 21, 2021

NovaBiotics Announces Publication of Data Elucidating NP339’s Broad Antifungal Activity in Antimicrobial Agents and Chemotherapy

Jun 1, 2021

NovaBiotics attending the BIO Digital Meeting, June 2021

May 21, 2021

Clear and unbiased facts about why the COVID 19/Pneumonia relationship is bad news

Mar 30, 2021

Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics

Feb 26, 2021

NovaBiotics Attending BIO CEO & Investor Digital Conference

Feb 2, 2021

Just when we thought things were getting better…..

Dec 31, 2020

CARE CF 1 oral Lynovex clinical trial data published

Dec 29, 2020

NovaBiotics in the press

Dec 28, 2020